The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Aloe‐emodin: A review of its pharmacology, toxicity, and pharmacokinetics
Abstract
Aloe‐emodin is a naturally anthraquinone derivative and an active ingredient of Chinese herbs, such as Cassia occidentalis, Rheum palmatum L., Aloe vera, and Polygonum multiflorum Thunb. Emerging evidence suggests that aloe‐emodin exhibits many pharmacological effects, including anticancer, antivirus, anti‐inflammatory, antibacterial, antiparasitic, neuroprotective, and hepatoprotective activities. These pharmacological properties lay the foundation for the treatment of various diseases, including influenza virus, inflammation, sepsis, Alzheimer's disease, glaucoma, malaria, liver fibrosis, psoriasis, Type 2 diabetes, growth disorders, and several types of cancers. However, an increasing number of published studies have reported adverse effects of aloe‐emodin. The primary toxicity among these reports is hepatotoxicity and nephrotoxicity, which are of wide concern worldwide. Pharmacokinetic studies have demonstrated that aloe‐emodin has a poor intestinal absorption, short elimination half‐life, and low bioavailability. This review aims to provide a comprehensive summary of the pharmacology, toxicity, and pharmacokinetics of aloe‐emodin reported to date with an emphasis on its biological properties and mechanisms of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Emodin enhances osteogenesis and inhibits adipogenesis
Yang, F., Yuan, P.-W., Hao, Y., & Lu, Z.-M. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-74 · Cited by 40
RetractedThe Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
Flier, J. S., Underhill, L. H., & Friedman, S. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282508 · Cited by 1,432
Composition and Applications of Aloe vera Leaf Gel
Hamman, J. H. (2008) · Molecules · doi:10.3390/molecules13081599 · Cited by 1,118
Anti‐cancer properties of anthraquinones from rhubarb
Huang, Q., Lu, G., Shen, H., Chung, M. C. M., & Ong, C. N. (2007) · Medicinal Research Reviews · doi:10.1002/med.20094 · Cited by 559
Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction
HO, T., WU, S., CHEN, J., LI, C., & HSIANG, C. (2007) · Antiviral Research · doi:10.1016/j.antiviral.2006.04.014 · Cited by 516
Shrimali, D., Shanmugam, M. K., Kumar, A. P., Zhang, J., Tan, B. K. H., Ahn, K. S., & Sethi, G. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.023 · Cited by 277
Kuo, P.-L., Lin, T.-C., & Lin, C.-C. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01900-8 · Cited by 218
Effects and mechanisms of aloe-emodin on cell death in human lung squamous cell carcinoma
Lee, H.-Z., Hsu, S.-L., Liu, M.-C., & Wu, C.-H. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01467-4 · Cited by 198
Emodin inhibits current through SARS-associated coronavirus 3a protein
Schwarz, S., Wang, K., Yu, W., Sun, B., & Schwarz, W. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.02.008 · Cited by 189
Hu, B., Zhang, H., Meng, X., Wang, F., & Wang, P. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.03.059 · Cited by 183
Cited by
Drug repurposing for cancer therapy
Xia, Y., Sun, M., Huang, H., & Jin, W.-L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01808-1 · Cited by 443
Metadata
- Authors
- Dong, X., Zeng, Y., Liu, Y., You, L., Yin, X., Fu, J., & Ni, J.
- Venue
- Phytotherapy Research
- Publisher
- Wiley
- Published
- 2019-11-03
- Volume
- 34
- Issue
- 2
- Pages
- 270-281
- ISSN
- 0951-418X (ISSN-L)
- 1099-1573
- OpenAlex
- W2408313511
- Cited by
- 591
- References
- 143
- FWCI
- 46.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.